Atherosclerotic Cardiovascular Heart Disease in Women

Slides:



Advertisements
Similar presentations
Patient Oriented Therapy Non STE ACS
Advertisements

Summary Prepared by Melvyn Rubenfire, MD
Barbara Furry RNC, MS, CCRN ACS: Still the Silent Killer of Women.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
1 Women & Heart Disease Julia C. Orri, Ph.D. Biol. 330 November 21, 2006.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Questions for Thelma McKenzie: 1.Should it be assumed that the learners know all of the terminology, or should a glossary be included for review? 2.What.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation? July
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
Coronary Artery Disease Angina Pectoris Unstable Angina Variant Angina Joseph D. Lynch, MD.
HILLSBOROUGH COUNTY SHERIFF’S DEPARTMENT Saving Our Law Officers From Sudden Death and Heart Attacks.
Cardiovascular Disease in Women Module I: Epidemiology.
Cardiovascular Disease in Women Module V: Prognosis and Treatment Outcomes.
Management of Stable Angina SIGN 96
Reducing Risk of Heart Disease & Stroke - A Life Long Quest Jeffrey P. Gold, M.D. University of Toledo Medical Center.
10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
Aspirin Resistance: Significance, Detection and Clinical Management of This Real Phenomenon Webcast May 10 th, 2004 Sponsored by.
The Renin-Angiotensin- Aldosterone System: Linking New Data and Mechanisms for Cardiovascular Risk Reduction VBWG.
Wayne Rosamond, et al. Circulation 2007;115; e69-e171.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
Morteza Naghavi, M.D. Society for Heart Attack Prevention and Eradication (SHAPE) Houston, TX Screening for Early Detection and Prevention of Heart Attack.
Acute Coronary Syndrome David Aymond, MD. ACS Definition: Myocardial ischemia typically due to atherosclerotic plaque rupture  Coronary thrombosis ACS.
BRIAN CLAYTON INTERNAL MEDICINE ADVISOR: ANNA MAE SMITH PRECEPTOR: DR. RAJESH PATEL Evidence Based Medicine Spring 2009.
Antiplatelet Interventions in Acute Coronary Syndromes.
Coronary Heart Disease (CHD) László Tornóci Inst. Pathophysiology Semmelweis University.
Acute Coronary Syndromes Risk-Stratification Pathophysiology Diagnosis Initial Therapy Risk-Stratification Risk-Stratification Invasive vs Conservative.
Insights from the PROMISE Trial Neha J. Pagidipati, MD MPH; Kshipra Hemal; Adrian Coles, PhD; Daniel B. Mark, MD MPH; Rowena J. Dolor, MD MHS; Patricia.
Rapid assessment of chest pain Dr Phil Avery Prince Philip Hospital Hywel Dda Health Board PCCS 18 th May 2011.
How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.
Josephine Mak Waikato Cardiothoracic Unit Journal Club
Women and Cardiovascular Disease
Boston University Medical Center Boston , MA
Case 66 year old male with PMH of HTN, DM, ESRD on renal replacement TIW, stroke in 2011 with right side residual weakness, atrial fibrillation, currently.
18th Annual Primary Care and Cardiovascular Symposium
Clinical Trial Commentary
Coronary Heart Disease
Risk Stratification of Chest Pain: Best Practices
The role of unknown risk factors in coronary heart disease
Reducing Adverse Outcomes after ACS in Patients with Diabetes Goals
The American College of Cardiology Presented by Dr. Adnan Kastrati
CORONARY ARTERY DISEASE
Evaluation of Patients with chest pain Admitted under General Medicine; Has clinical judgment being taken over by serial troponins? Dr. Samantha Herath.
The European Society of Cardiology Presented by Dr. Bo Lagerqvist
Preventing Cardiovascular Disease
Clinical need for determination of vulnerable plaques
Women, Bleeding, and Coronary Intervention
Alina M. Allen MD, Patrick S. Kamath MD, Joseph J. Larson,
Gender Disparity in Treatment of Coronary Artery Disease?
Phenotype vs. Genotype: Defining Severe Familial Hypercholesterolemia
Heart Health & Diabetes
Section I: RAS manipulation C. Update on clinical trials in CAD
This series of slides highlights a report on a symposium at the European Society of Cardiology Congress held in Munich, Germany from August 28 to September.
Section A: Introduction
European Heart Association Journal 2007 April
Invasive versus conservative treatment in unstable coronary syndromes
TIMI IIIA Protocol Design 391 Patients with Unstable Angina / NQWMI
The European Society of Cardiology Presented by RJ De Winter
American College of Cardiology Presented by Dr. Michel R. Le May
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,
ARISE Trial Aggressive Reduction of Inflammation Stops Events
HILLSBOROUGH COUNTY SHERIFF’S DEPARTMENT
The following slides highlight a report on a presentation at the American College of Cardiology 2004, Scientific Sessions, in New Orleans, Louisiana on.
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

Atherosclerotic Cardiovascular Heart Disease in Women Millee Singh DO Non Invasive Cardiology First Coast Heart and Vascular

Overview More than one in three female adults has some form of cardiovascular disease (CVD) Since 1984, the number of CVD deaths for females has exceeded those for males On average Females represented 51.0% of deaths from CVD  In 2010, CVD was the first listed diagnosis of 2.8 million females discharged from short-stay hospitals Most recent data show that 25.1% of bypass and 32.9% of PCI ,31.3% of heart transplant patients were female Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update;Myamericanheart.org

CVD Male CVD Female Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update;Myamericanheart.org

Coronary Heart Disease In Women  About 6.6 million females alive today have CHD Of these, 2.6 million have a history of myocardial infarction (MI, or heart attack) Each year new and recurrent MI and fatal CHD will impact an estimated 380,000 women 26% of women age 45 and older who have an initial recognized MI (heart attack) die within a year compared with 19% of men  64% of women who died suddenly of CHD had no previous symptoms Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update;Myamericanheart.org

Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update;Myamericanheart.org

Angina Pectoris  More women than men have angina in total numbers (4.1 million vs. 3.7 million)  Angina among non-Hispanic women age 20 and older: 2.8% of non-Hispanic whites 5.4% of non-Hispanic blacks 3.3% of Mexican Americans Each year about 180,000 women over age 45 are diagnosed with stable angina Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update;Myamericanheart.org

CVD Stroke Lung CA Breast CA Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update;Myamericanheart.org

Clinical Presentation Women with CHD are generally about 10 years older than men at the time of presentation Although women are generally older than men at presentation, women younger than age 45 years also develop CHD and have a worse prognosis than men The first presentation of CHD may be chest pain, myocardial infarction (MI), heart failure (HF), or sudden cardiac death (SCD) The Framingham Risk Estimation underestimates risk in women -the Reynolds Risk Score, have been developed specifically for use in women Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update;Myamericanheart.org

SYMPTOMS: CHEST PAIN While differences between women and men -there are more similarities than differences! Chest pain is the most common anginal symptom in both sexes with regard to: Quality of pain (heaviness, pressure) Pattern of radiation Associated symptoms The quality of chest pain (typical versus atypical) is an important predictor of angiographic disease in women Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update;Myamericanheart.org

Unrecognized/Asymptomatic MI MI in women may go unrecognized, particularly at younger ages and when compared to men: Icelandic study : 13,000 women were followed for 29 years MI that went unrecognized was higher in the younger women (41 versus 24 %) 2003,a report In Circulation ; of 515 women with an acute MI, acute chest pain was absent in 43 % and only 30 % experienced prodromal chest pain 2012 , Jama ; study of over 1,000,000 women and men in the National Registry of Myocardial Infarction (United States) the proportion of MI patients who presented without chest pain was significantly higher for women than men (42.0 versus 30.7 %) McSweeney JC, Cody M, O'Sullivan P, et al. Women's early warning symptoms of acute myocardial infarction. Circulation 2003; 108:2619 Canto JG, Rogers WJ, Goldberg RJ, et al. Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA 2012; 307:813.

NSTEMI Optimal approach to accurate assessment of risk in women with a non-ST elevation ACS may differ from that in men TACTICS-TIMI 18: Women were more likely to have elevations of hs-CRP, BNP, and less likely to have elevations of troponins and CKMB, than men, despite similar levels of risk Women with any positive marker benefited from an invasive strategy Women with no positive markers benefited from a conservative strategy Men benefited from an invasive strategy when there was biomarker positivity and no differnence in benefit if they were negative Women with unstable angina Without positive biomarkers should be treated conservatively, without early catheterization or use of glycoprotein IIb/IIIa inhibitors

SCD Sudden cardiac death — A 38-year follow-up from the Framingham Heart study

Testing In Women Treadmill stress testing Nuclear stress testing Stress echo CT calcium score Coronary CTA Cardiac catheterization with coronary angiography

How good are the tests? Sen/Spec ETT only (lower than in men) 61% and 70% Stress Nuclear (similar in men) 78% and 64% Stress Echo (similar in men) 86% and 79%

As for CCTA, Where does this stand? ROMICAT trial Women had greater reduction in LOS, lower admission rates, lower radiation doses More normal studies, less obstructive dz Lower radiation doses then a nuclear medicine scan Focal radiation to the breast is present- no confirmed link to increased in Breast CA

Radiation Exposure for Women Courtesy of Ana Barac, MD, ACC HWH 2014

Positive Test ? What next? Women less likely to be referred for further evaluation if they have a positive stress test! Higher incidence of MI or death in these patients have been noted

Cardiac Catheterization Less likely to be referred Higher complication rate than in men Smaller arteries, more bleeding But these pts do better than if no intervention Higher peri-procedural rate of complication but better long-term survival than men

Preventative Measures All Women Exercise Quit smoking Healthy diet BMI <25, waist circumference <35 in. Treat risk factors: HTN, DM, dyslipidemia ASA – look at risk/benefit ratio

DDX Women’s ischemic heart disease (syndrome X, micro vascular disease) Myocarditis Stress-induced cardiomyopathy Coronary dissection

Key Points CAD and CVD are by far the biggest health risks for women Awareness is still less than it needs to be Prevention CAN reduce risk Screening programs are available Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update;Myamericanheart.org

Key Points Women can present differently, and do worse when they do Women are referred less often for appropriate testing and treatment Women can have more complications from treatment, but still fare better than without treatment